NO20042440L - Oral doseringsform av et sulfonamid prolegemiddel sa som parecoxib - Google Patents

Oral doseringsform av et sulfonamid prolegemiddel sa som parecoxib

Info

Publication number
NO20042440L
NO20042440L NO20042440A NO20042440A NO20042440L NO 20042440 L NO20042440 L NO 20042440L NO 20042440 A NO20042440 A NO 20042440A NO 20042440 A NO20042440 A NO 20042440A NO 20042440 L NO20042440 L NO 20042440L
Authority
NO
Norway
Prior art keywords
parecoxib
dosage form
oral dosage
sulfonamide
prodrug
Prior art date
Application number
NO20042440A
Other languages
English (en)
Norwegian (no)
Inventor
Aziz Karim
Sandeep Nema
Gary D Ewing
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Publication of NO20042440L publication Critical patent/NO20042440L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20042440A 2001-11-13 2004-06-11 Oral doseringsform av et sulfonamid prolegemiddel sa som parecoxib NO20042440L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35059601P 2001-11-13 2001-11-13
PCT/US2002/036253 WO2003041705A1 (en) 2001-11-13 2002-11-12 Oral dosage form of a sulfonamide prodrug such as parecoxib

Publications (1)

Publication Number Publication Date
NO20042440L true NO20042440L (no) 2004-08-09

Family

ID=23377399

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042440A NO20042440L (no) 2001-11-13 2004-06-11 Oral doseringsform av et sulfonamid prolegemiddel sa som parecoxib

Country Status (20)

Country Link
US (1) US20030100595A1 (de)
EP (1) EP1446118B1 (de)
JP (1) JP2005509002A (de)
KR (1) KR20050044459A (de)
CN (1) CN1615135A (de)
AR (1) AR037356A1 (de)
AT (1) ATE383156T1 (de)
BR (1) BR0214081A (de)
CA (1) CA2466504A1 (de)
CO (1) CO5580744A2 (de)
DE (1) DE60224558T2 (de)
ES (1) ES2297032T3 (de)
IL (1) IL161991A0 (de)
MX (1) MXPA04004476A (de)
NO (1) NO20042440L (de)
PL (1) PL369962A1 (de)
RU (1) RU2004114552A (de)
TW (1) TW200300680A (de)
WO (1) WO2003041705A1 (de)
ZA (1) ZA200403328B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7785640B2 (en) * 2004-01-16 2010-08-31 Amerilab Technologies, Inc. Effervescent composition including cranberry extract
EP1799196B1 (de) 2004-10-08 2016-06-22 Forward Pharma A/S Pharmazeutische zusammensetzung mit kontrollierter freisetzung mit einem fumarsäureester
CA2622286A1 (en) * 2005-09-27 2007-04-05 University Of Kentucky Research Foundation Anti-inflammatory composition comprising berry extract
EP1940382A2 (de) * 2005-10-07 2008-07-09 Aditech Pharma AB Kombinationstherapie mit fumarsäureestern zur behandlung von autoimmunkrankheiten und/oder entzündlichen erkrankungen
CA2661274A1 (en) * 2006-08-29 2008-03-06 University Of Kentucky Research Foundation Compositions and methods for oral cancer chemoprevention using berry preparations and extracts
EP1902708A1 (de) 2006-09-25 2008-03-26 Losan Pharma GmbH Wirkstoff enthaltende stabilisierte feste Arzneimittelformen und Verfahren zu ihrer Herstellung
NZ585310A (en) * 2007-10-12 2012-02-24 Astrazeneca Ab Composition 064
UA125896C2 (uk) 2009-01-09 2022-07-06 Фвп Іп Апс Фармацевтичний склад, що містить в матриці, яка піддається ерозії, один або більше ефірів фумарової кислоти
JP6102120B2 (ja) * 2012-08-16 2017-03-29 ニプロ株式会社 医薬製剤およびその製造方法
CN104771370B (zh) * 2014-01-14 2020-07-24 南京圣和药业股份有限公司 帕瑞昔布钠冻干粉针剂及其制备方法
CN104965041B (zh) * 2015-06-11 2016-06-29 成都克莱蒙医药科技有限公司 一种帕瑞昔布钠异构体的高效液相色谱检测方法
CN106074399B (zh) * 2016-06-21 2018-11-02 马鞍山丰原制药有限公司 一种帕瑞昔布钠冻干制剂及其制备方法
CN112409283A (zh) * 2020-11-24 2021-02-26 苏州璞正医药有限公司 一种帕瑞昔布衍生物及其制备方法和应用
CN118767141A (zh) * 2023-04-04 2024-10-15 上海汇伦医药股份有限公司 西维来司他用于镇痛的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0729748B1 (de) * 1993-11-18 2003-02-26 Nippon Shinyaku Company, Limited Verfahren zur herstellung stabiler arzneimittel
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
BR9708574A (pt) * 1996-04-12 1999-08-03 Searle & Co Derivados benzeno sulfonamida substituídos como pródrogas de inibidores cox-2
SE9703693D0 (sv) * 1997-10-10 1997-10-10 Astra Pharma Prod Novel combination
AU8026200A (en) * 1999-10-19 2001-04-30 Board Of Regents, The University Of Texas System Treatment of heart disease with cox-2 inhibitors
WO2001041761A2 (en) * 1999-12-08 2001-06-14 Pharmacia Corporation Valdecoxib compositions
BR0016705A (pt) * 1999-12-22 2002-09-24 Pharmacia Corp Composições de liberação dupla de um inibidor de ciclooxigenase-2
DK1265859T3 (da) * 2000-03-24 2006-05-01 Pharmacia Corp Amidinoforbindelser der er nyttige som nitrogenoxidsyntaseinhibitorer
AR035642A1 (es) * 2000-05-26 2004-06-23 Pharmacia Corp Uso de una composicion de celecoxib para el alivio rapido del dolor
US6306842B1 (en) * 2000-06-02 2001-10-23 Medinox, Inc. Protected forms of a combination of pharmacologically active agents and uses therefor
JP2004503588A (ja) * 2000-07-13 2004-02-05 ファルマシア・コーポレーション 全身性疼痛および頭痛に対する選択的シクロオキシゲナーゼ−２阻害薬および血管調節化合物
MY137736A (en) * 2001-04-03 2009-03-31 Pharmacia Corp Reconstitutable parenteral composition

Also Published As

Publication number Publication date
AR037356A1 (es) 2004-11-03
BR0214081A (pt) 2004-09-28
DE60224558T2 (de) 2009-01-22
ZA200403328B (en) 2005-04-13
US20030100595A1 (en) 2003-05-29
TW200300680A (en) 2003-06-16
RU2004114552A (ru) 2005-02-20
PL369962A1 (en) 2005-05-02
EP1446118A1 (de) 2004-08-18
CN1615135A (zh) 2005-05-11
MXPA04004476A (es) 2004-08-11
ES2297032T3 (es) 2008-05-01
JP2005509002A (ja) 2005-04-07
DE60224558D1 (de) 2008-02-21
WO2003041705A1 (en) 2003-05-22
CA2466504A1 (en) 2003-05-22
IL161991A0 (en) 2005-11-20
CO5580744A2 (es) 2005-11-30
EP1446118B1 (de) 2008-01-09
KR20050044459A (ko) 2005-05-12
ATE383156T1 (de) 2008-01-15

Similar Documents

Publication Publication Date Title
NO20042440L (no) Oral doseringsform av et sulfonamid prolegemiddel sa som parecoxib
NO20042807L (no) Farmasoytiske sammensetninger som innbefatter aktive vitamin D forbindelser
ATE296619T1 (de) Feste orale dosierungsform von simethicon
IS6969A (is) Sýklóprópýlindólafleiður sem sérhæfðir tálmar endurupptöku serótoníns
CY2013036I2 (el) Συνθεσεις εμβολιου κατα της ναϊσσερια, που περιεχουν εναν συνδυασμο αντιγονων
IS2571B (is) Munntökuform af própívíríni, þannig útbúið að hinum virka þætti er sleppt út á löngum tíma
CY2018005I2 (el) Απο του στοματος φαρμακοτεχνικες μορφες της κλαντριβινης
DK1414409T3 (da) Stabiliseret oral suspensionsformulering
NO20033343D0 (no) Farmasöytiske doseringsformer av epothiloner for oral administrasjon
DK1545475T3 (da) Enterisk sammensætning til fremstillingen af blød kapselvæg
NO20052474D0 (no) Amort form av esomeprazolsalter
IS7051A (is) Lyfjasamsetningar
EE200300537A (et) Meetod madalaannuselise farmatseutilise kompositsiooni tootmiseks
PT1136081E (pt) Composicoes de libertacao controlada para a administracao parenterica de microlidos
DK1458413T3 (da) Farmaceutiske sammensætninger på b asis af azetidin-derivater
NO20034556D0 (no) Imidazotriazinon-holdige sammensetninger for nasal administrering
IS2707B (is) Nýjar lyfjasamsetningar úr módafíníli
IS7219A (is) Lyfjablanda sem inniheldur (R) -bíkalútamíð
DE60235195D1 (de) Vitamin-d-analoga
NO20040857L (no) Ny oral forlenget frigivelses doseringsform.
NO20035547D0 (no) Fremgangsmåte for fremstilling av paroksetin HCl som begrenser dannelse avrosafargede forbindelser
FR2838339B1 (fr) Derives poly-phosphonates pour compositions dentifrices
NO20041859D0 (no) Oral rehydration salts
NO20033809D0 (no) Metronomisk dosering av taxaner
FI20012242A0 (fi) Uudet farmaseuttiset yhdisteet

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application